Daniel Camardo
Net worth: 556 336 $ as of 31/08/2026
Net worth: 556 336 $ as of 31/08/2026
Mr. Daniel A. Camardo is on the Board of Directors at Cue Biopharma, Inc. and CommunityHealth NFP.
Mr. Camardo was previously employed as a President-North America by Immedica Pharma AB, a Chief Executive Officer, Secretary, Director & CAO by Athersys, Inc., a President-US & Executive Vice President by Horizon Therapeutics Ltd. (Ireland), a Vice President-Sales & Operations by Clarus Therapeutics, Inc., and a Senior Director-US Commercial Operations by Astellas Pharma US, Inc. He received his undergraduate degree from Rochester Christian University and an MBA from Kellogg School of Management.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 09/07/2026 | 21,800 ( 0.3% ) | 556 336 $ | 31/08/2026 |
| Companies | Position | Start |
|---|---|---|
| CUE BIOPHARMA, INC. | Director/Board Member | 30/05/2026 |
CommunityHealth NFP
CommunityHealth NFP Medical/Nursing ServicesHealth Services Provides free primary, specialty care, women's health, behavioral health, pharmacy and preventive healthcare services | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| ATHERSYS, INC. | Chief Executive Officer | 31/12/2023 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 01/02/2022 |
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for men hypogonadism | Sales & Marketing | 01/09/2015 |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2004 |
Immedica Pharma AB
Immedica Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops medicines for rare, genetic and metabolic diseases, hematology & oncology and specialty care | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
Rochester Christian University
Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for men hypogonadism | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Athersys, Inc.
Athersys, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops novel and proprietary therapies | Health Technology |
Immedica Pharma AB
Immedica Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops medicines for rare, genetic and metabolic diseases, hematology & oncology and specialty care | Health Technology |
CommunityHealth NFP
CommunityHealth NFP Medical/Nursing ServicesHealth Services Provides free primary, specialty care, women's health, behavioral health, pharmacy and preventive healthcare services | Health Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Select your edition
All financial news and data tailored to specific country editions